<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT943-11508</title>
	</head>
	<body>
		<main>
			<p>940729 FT  29 JUL 94 / International Company News: Bristol-Myers joins Cadus Bristol-Myers Squibb, US drug company, has signed its biggest collaborative deal with a biotechnology company, writes Daniel Green. Its partner in the deal, worth up to Dollars 45m, is New York's Cadus Pharmaceutical, a specialist in rapid screening of large numbers of potential drugs. Under the agreement, BMS will take a 15 per cent stake in Cadus. It has also committed itself to additional equity investments, on the achievement of certain scientific milestones, and to further Cadus fund raising, including flotation. Cadus receives up to five years of research funding for work into the way hormones or drugs work in the body.</p>
		</main>
</body></html>
            